Proove Biosciences Announces Industry Leading Board of Directors

Share Article

Life Sciences Industry Leaders Join Board from Various Sectors including Government, Accounting, and Pharmacy Industries

the Company is honored to have these industry leaders support our mission - Brian Meshkin, President & CEO

Today,Proove Biosciences, a commercial and research leader in personalized medicine announces appointments to the Company’s Board of Directors.

In addition to the Company’s founder and Chief Executive Officer,Brian Meshkin, Proove Biosciences, has appointed Governor Michael Leavitt, the former Secretary of the U.S. Department of Health and Human Services and former Governor of Utah; Jean-Pierre Millon, current Board member of CVS Health and former President and CEO of PCS Health Systems; and Don Williams, the former National Leader of Grant Thornton’s Life Sciences practice.

“Building on Proove’s track record of success, the Company is honored to have these industry leaders support our mission,” states Proove CEO Brian Meshkin. “Not only does this validate the tremendous achievements of our employees and the hundreds of researchers who have worked with us across the nation, but it underscores the importance we place on strong corporate governance and good corporate citizenship .”

About Proove Biosciences
Our Mission is to Change the Future of Medicine. Proove is the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could’ve ever prescribed medications without knowing how a patient would respond. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of personalized pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve outcomes – both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit or call toll free 855-PROOVE-BIO (855-776-6832).

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole McMillan
Proove Biosciences
+1 855-776-6832 Ext: 1546
Email >
Follow >
Proove Biosciences, Inc.
since: 02/2012
Like >
Proove Biosciences, Inc.